BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9826980)

  • 1. A clinical overview of treatment decisions in the management of spasticity.
    Gormley ME; O'Brien CF; Yablon SA
    Muscle Nerve Suppl; 1997; 6():S14-20. PubMed ID: 9826980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quantitative measurement of spasticity: effect of cutaneous electrical stimulation.
    Seib TP; Price R; Reyes MR; Lehmann JF
    Arch Phys Med Rehabil; 1994 Jul; 75(7):746-50. PubMed ID: 8024418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spasticity. Mechanisms and nursing care.
    St George CL
    Nurs Clin North Am; 1993 Dec; 28(4):819-27. PubMed ID: 8265421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spasticity after spinal cord injury.
    Adams MM; Hicks AL
    Spinal Cord; 2005 Oct; 43(10):577-86. PubMed ID: 15838527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders.
    Yablon SA
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):833-74, vii-viii. PubMed ID: 11723867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic and clinical monitoring of spastic hypertonia.
    Hinderer SR; Dixon K
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):733-46. PubMed ID: 11723863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spasticity. Physical therapy, preventive measures and treatment].
    Gay S; Egon G
    Ann Fr Anesth Reanim; 2005 Jun; 24(6):663-6. PubMed ID: 15950113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A.
    Guettard E; Roze E; Abada G; Lemesle C; Vidailhet M; Laurent-Vannier A; Chevignard MP
    Dev Neurorehabil; 2009 Jun; 12(3):128-38. PubMed ID: 19466620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between self- and clinically rated spasticity in spinal cord injury.
    Lechner HE; Frotzler A; Eser P
    Arch Phys Med Rehabil; 2006 Jan; 87(1):15-9. PubMed ID: 16401432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The application of botulinum toxin type A in the treatment of spastic paraparesis].
    Sobolewski P
    Przegl Lek; 2007; 64 Suppl 2():3-7. PubMed ID: 17953270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis effect on spasticity in spinal cord injury.
    Malec J; Harvey RF; Cayner JJ
    Arch Phys Med Rehabil; 1982 Mar; 63(3):116-8. PubMed ID: 6978699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
    Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb.
    Turner-Stokes L; Ashford S
    Disabil Rehabil; 2007 Dec; 29(23):1806-12. PubMed ID: 18033605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin treatment of adult spasticity.
    Sheean G
    Expert Rev Neurother; 2003 Nov; 3(6):773-85. PubMed ID: 19810880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S; Turner-Stokes L
    Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rehabilitation medicine: 3. Management of adult spasticity.
    Satkunam LE
    CMAJ; 2003 Nov; 169(11):1173-9. PubMed ID: 14638654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A database of self-reported secondary medical problems among VA spinal cord injury patients: its role in clinical care and management.
    Walter JS; Sacks J; Othman R; Rankin AZ; Nemchausky B; Chintam R; Wheeler JS
    J Rehabil Res Dev; 2002; 39(1):53-61. PubMed ID: 11926327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulin toxin for spasticity in spinal cord damage by treating the motor endplate].
    Keren O; Shinberg F; Catz A; Giladi N
    Harefuah; 2000 Feb; 138(3):204-8, 270. PubMed ID: 10883093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
    Opara J; Hordyńska E; Swoboda A
    Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.